Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Jing Shi Ang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Dermatology|June 4, 2024
An enlarging painless eyelid noduleAndrea Jing Shi Ang, Fan Foon Cheo, Choon Chiat Oh
Asia-Pacific Journal of Clinical Oncology|September 3, 2020
Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian CenterKennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 5, 2025
Outcomes of Prolonged Provocation Testing in Penicillin Allergy EvaluationAndrea Jing Shi Ang, Haur Yueh Lee, Chaw Su Naing, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2022
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Liver Cancer|February 28, 2022
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular CarcinomaKennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, et al.
Asia-Pacific Journal of Clinical Oncology|November 27, 2024
Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular CarcinomaKennedy Yao Yi Ng, Albert Eng Keong Teo, Sze Huey Tan, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Dermatology|June 4, 2024
An enlarging painless eyelid noduleAndrea Jing Shi Ang, Fan Foon Cheo, Choon Chiat Oh
Asia-Pacific Journal of Clinical Oncology|September 3, 2020
Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian CenterKennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 5, 2025
Outcomes of Prolonged Provocation Testing in Penicillin Allergy EvaluationAndrea Jing Shi Ang, Haur Yueh Lee, Chaw Su Naing, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2022
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Liver Cancer|February 28, 2022
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular CarcinomaKennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, et al.
Asia-Pacific Journal of Clinical Oncology|November 27, 2024
Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular CarcinomaKennedy Yao Yi Ng, Albert Eng Keong Teo, Sze Huey Tan, et al.
Pageof 1